- OPORTUNIDADES DE INVERSIÓN
- CÓMO FUNCIONA
- ENVÍA TU PROYECTO
Finding novel and specific drug targets which are more efficacious and likely to pass the FDA at the end of the clinical trials will save Big Pharma huge amounts of money and time invested during development.
I really like the approach, and as far as I know, it is a market niche that is still launching.
Team seems to have strong expertise on drug development, both in research and private companies. Technical expertise on the field is strong.